Center-Authored Papers

Filters: Author is Shulman, Howard M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Lesnikov V, Gorden N, Fausto N, Spaulding E, Campbell J, Shulman HM, Fleming RE, Deeg HJ.  2008.  Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.. Apoptosis : an international journal on programmed cell death. 13(8):1005-12. Abstract
Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly KM, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK et al..  2008.  Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PloS one. 3(1):e1452. Abstract
2009
Deeg HJ, Spaulding E, Shulman HM.  2009.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.. Leukemia & lymphoma. 50(10):1566-72. Abstract
Bair S, Spaulding E, Parkkinen J, Shulman HM, Lesnikov V, Beauchamp M, Canonne-Hergaux F, Kowdley KV, Deeg HJ.  2009.  Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.. Blood. 113(8):1841-4. Abstract
Sakai M, Strasser SI, Shulman HM, McDonald SJ, Schoch HG, McDonald GB.  2009.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.. Bone marrow transplantation. 44(7):441-7. Abstract
Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM.  2009.  Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.. PloS one. 4(7):e6203. Abstract
2010
Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB et al..  2010.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(7):1005-17. Abstract
2011
Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM, Shulman HM, Goldmuntz E, Mayes M, Parikh CR et al..  2011.  Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):674-81. Abstract
2012
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
2014
Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C.  2014.  Late onset colitis after cord blood transplant is consistent with Graft-Versus-Host Disease: Results of a blinded histopathological review.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(7):1008-13. Abstract
Stift J, Baba HA, Huber E, Federmann B, Fischer H-P, Schmitt-Graeff A, Baurmann H, Bethge W, Schirmacher P, Wrba F et al..  2014.  Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.. Virchows Archiv : an international journal of pathology. 464(2):175-90. Abstract
Acute Kidney Injury
Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM, Shulman HM, Goldmuntz E, Mayes M, Parikh CR et al..  2011.  Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):674-81. Abstract
Adolescent
Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB et al..  2010.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(7):1005-17. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Stift J, Baba HA, Huber E, Federmann B, Fischer H-P, Schmitt-Graeff A, Baurmann H, Bethge W, Schirmacher P, Wrba F et al..  2014.  Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.. Virchows Archiv : an international journal of pathology. 464(2):175-90. Abstract
Sakai M, Strasser SI, Shulman HM, McDonald SJ, Schoch HG, McDonald GB.  2009.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.. Bone marrow transplantation. 44(7):441-7. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Adoptive Transfer
Bair S, Spaulding E, Parkkinen J, Shulman HM, Lesnikov V, Beauchamp M, Canonne-Hergaux F, Kowdley KV, Deeg HJ.  2009.  Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.. Blood. 113(8):1841-4. Abstract
Adult
Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM, Shulman HM, Goldmuntz E, Mayes M, Parikh CR et al..  2011.  Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):674-81. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Sakai M, Strasser SI, Shulman HM, McDonald SJ, Schoch HG, McDonald GB.  2009.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.. Bone marrow transplantation. 44(7):441-7. Abstract
Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB et al..  2010.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(7):1005-17. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Evans AT, Loeb KR, Shulman HM, Hassan S, Qiu WC, Hockenbery DM, Ioannou GN, Chauncey TR, Gretch DR, McDonald GB.  2015.  Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.. The American journal of surgical pathology. 39(2):212-20. Abstract